Abstract
Both osteoporosis and hypertension are major diseases in aging populations. This work was provided to investigate the possible effect of the nonselective beta adrenoceptor antagonist; carvedilol against postmenopausal osteoporosis in adult rats. Ovariectomized rats were gavaged with carvedilol (10 mg/kg) daily for 60 days. Serum levels of estradiol, calcium and osteoblastic markers (alkaline phosphatase and osteocalcin) were measured. The bone resorbing cytokines (TNF-α and IL-6) were also evaluated. The oxidative stress markers were determined via measuring the lipid peroxidation product and the anti-oxidant markers in the serum. The bones were prepared for histomorphometric study. In comparison to the ovariectomized rats, carvedilol caused significant attenuation of the bone loss, biomechanical fragility, bone resorbing cytokines and oxidative stress. Current evidence suggests that administration of carvedilol has a beneficial effect on the bone quality in OVX rats via its antioxidant effect and attenuation of the bone resorbing cytokines.
Keywords: Beta blocker, carvedilol, IL-6, osteoporosis, oxidative stress, TNF-α.
Current Drug Therapy
Title:The Potential Effect of Carvedilol Against Osteoporosis in Ovariectomized Rats
Volume: 8 Issue: 3
Author(s): Vivian Boshra and Gehan Abdel Hamid El Wakeel
Affiliation:
Keywords: Beta blocker, carvedilol, IL-6, osteoporosis, oxidative stress, TNF-α.
Abstract: Both osteoporosis and hypertension are major diseases in aging populations. This work was provided to investigate the possible effect of the nonselective beta adrenoceptor antagonist; carvedilol against postmenopausal osteoporosis in adult rats. Ovariectomized rats were gavaged with carvedilol (10 mg/kg) daily for 60 days. Serum levels of estradiol, calcium and osteoblastic markers (alkaline phosphatase and osteocalcin) were measured. The bone resorbing cytokines (TNF-α and IL-6) were also evaluated. The oxidative stress markers were determined via measuring the lipid peroxidation product and the anti-oxidant markers in the serum. The bones were prepared for histomorphometric study. In comparison to the ovariectomized rats, carvedilol caused significant attenuation of the bone loss, biomechanical fragility, bone resorbing cytokines and oxidative stress. Current evidence suggests that administration of carvedilol has a beneficial effect on the bone quality in OVX rats via its antioxidant effect and attenuation of the bone resorbing cytokines.
Export Options
About this article
Cite this article as:
Boshra Vivian and Hamid El Wakeel Abdel Gehan, The Potential Effect of Carvedilol Against Osteoporosis in Ovariectomized Rats, Current Drug Therapy 2013; 8 (3) . https://dx.doi.org/10.2174/15748855113086660010
DOI https://dx.doi.org/10.2174/15748855113086660010 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Angiotensin Peptides as AT2 Receptor Agonists
Current Protein & Peptide Science Mechanisms and Inhibitors of Apoptosis in Cardiovascular Diseases
Current Pharmaceutical Design Mechanical Ventilation of the Neonate: Principles and Strategies
Current Respiratory Medicine Reviews Therapeutic Perspectives on Pancreatic Cancer
Current Cancer Drug Targets Ageing and Nutritional Therapy Adherence in Type 2 Diabetes
Current Diabetes Reviews Modulation of Inducible Nitric Oxide Synthase Activation by Immuno-suppressive Drugs
Current Drug Metabolism Sex-Gender Differences in Diabetes Vascular Complications and Treatment
Endocrine, Metabolic & Immune Disorders - Drug Targets A Critical and Comprehensive Insight on Heme Oxygenase and Related Products Including Carbon Monoxide, Bilirubin, Biliverdin and Ferritin in Type-1 and Type-2 Diabetes
Current Pharmaceutical Design The Synthesis of Coenzyme Q10
Current Organic Chemistry Study of drug-drug combinations based on molecular descriptors and physicochemical properties
Combinatorial Chemistry & High Throughput Screening Craniocervical Dissections: Radiologic Findings, Pitfalls, Mimicking Diseases: A Pictorial Review
Current Medical Imaging Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin
Current Neurovascular Research Should Adipokines be Considered in the Choice of the Treatment of Obesity-Related Health Problems?
Current Drug Targets Morphology of Atherosclerotic Plaque: Its Feature by Imaging Study
Current Pharmaceutical Design Palmitic Acid Grafted Maize Starch (PAgMS) Nanoparticles as Potential Drug Carrier for Irbesarten: In Vitro and In Vivo Evaluation
Current Nanomedicine Cardiovascular Risk and Endothelial Dysfunction: The Preferential Route for Atherosclerosis
Current Pharmaceutical Biotechnology Recent Advances in Management of Diabetic Macular Edema
Current Diabetes Reviews Impact of Nutrition Transition and Resulting Morbidities on Economic and Human Development
Current Diabetes Reviews Age-Related Changes in P-Glycoprotein Expression in Senescence- Accelerated Mouse
Current Aging Science Genetic and Environmental Risk Factors in Hyperuricaemia and Common Gout
Current Rheumatology Reviews